• Annexin V, Human Recombinant: Advanced Strategies for High-P

  2026-04-29

  Discover how Annexin V, a premier phosphatidylserine binding protein, enables high-precision apoptosis detection and advanced cell death research. This article uniquely explores its mechanistic depth, protocol optimization, and translational impact in oncology.

• Dihydroartemisinin: Applied Protocols in mTOR & Malaria Rese

  2026-04-28

  Dihydroartemisinin, derived from Artemisia plant extract, empowers advanced research in mTOR signaling and antimalarial assays with precision and reproducibility. This guide delivers stepwise experimental workflows, troubleshooting strategies, and actionable insights for maximizing the scientific impact of this potent agent from APExBIO.

• Kanamycin Sulfate: Mechanistic Insight and Translational Imp

  2026-04-28

  Explore the mechanistic precision and strategic utility of Kanamycin Sulfate in translational research. This article blends biological rationale, competitive evidence, and actionable guidance to empower robust microbiology and antibiotic resistance studies, showcasing how APExBIO’s high-purity Kanamycin Sulfate stands apart in supporting modern workflows.

• Patient-Derived 3D Spheroid Models Advance Prostate Cancer R

  2026-04-27

  This study establishes robust patient-derived 3D spheroid cultures from radical prostatectomy samples as physiologically relevant models of organ-confined prostate cancer. The work demonstrates their viability for long-term culture, preservation, and drug response profiling, offering a translational bridge between clinical specimens and experimental therapeutics.

• Applied Workflows with Enhanced ECL Chemiluminescent Detecti

  2026-04-27

  Unlock ultra-sensitive western blot protein quantification with the Enhanced ECL Chemiluminescent Substrate Detection Kit. APExBIO's solution offers unmatched sensitivity, streamlined protocols, and robust performance for antibody detection assays—even in demanding resistance mechanism studies.

• Firefly Luciferase mRNA: Optimized 5-moUTP Reporter Workflow

  2026-04-26

  EZ Cap™ Firefly Luciferase mRNA (5-moUTP) accelerates robust gene expression assays by combining advanced immune evasion with exceptional mRNA stability. Unlock reproducible, high-sensitivity bioluminescent reporting for cell-based and in vivo applications, leveraging breakthroughs in mRNA delivery and workflow optimization.

• SR-202 in Insulin Resistance & Obesity Research: Protocols &

  2026-04-25

  SR-202, a selective PPARγ antagonist, is reshaping workflows in insulin resistance and obesity research by enabling precise dissection of adipogenesis and immunometabolic signaling. This guide delivers actionable protocols, troubleshooting strategies, and translational insights for deploying SR-202 in advanced metabolic and immune studies.

• Penicillin G Sodium: Optimized Protocols for Reliable Bacter

  2026-04-24

  Penicillin G Sodium from APExBIO sets the benchmark for reproducible, high-fidelity Gram-positive bacterial control in both research and clinical workflows. This guide delivers actionable protocol enhancements, troubleshooting strategies, and cross-study insights to maximize the antibiotic’s value in contamination prevention and experimental design.

• Applied Use-Cases for the One-step TUNEL FITC Apoptosis Dete

  2026-04-24

  Unlock robust, reproducible apoptosis detection in tissue sections and cultured cells with the One-step TUNEL FITC Apoptosis Detection Kit. This guide delivers practical workflow enhancements, troubleshooting strategies, and insights from recent neurotoxicity research, making it indispensable for translational and preclinical labs.

• Bile Acid Metabolism Subtypes Reveal Immune Markers in CRC

  2026-04-23

  Feng et al. (2026) identified molecular subtypes of colorectal cancer (CRC) based on bile acid metabolism, revealing CLCA1, UGT2A3, and ZG16 as key markers linked to immune dysfunction and prognosis. This integrative approach offers new insight into tumor immune microenvironment (TIME) stratification and potential biomarker-driven research.

• RNA Pol II Inhibition Triggers Apoptosis via PDAR, Not mRNA

  2026-04-23

  Harper et al. (2025) demonstrate that inhibition of RNA polymerase II (Pol II) activates cell death through an active signaling pathway termed the Pol II degradation-dependent apoptotic response (PDAR), independent of global transcription loss. This mechanistic insight shifts the paradigm for understanding apoptosis in response to transcriptional inhibition, with implications for cancer therapy research.

• Antimycin A4: An ATP-Citrate Lyase Inhibitor for Energy Rese

  2026-04-22

  Antimycin A4’s dual inhibition of ATP-citrate lyase and the mitochondrial respiratory chain delivers unrivaled precision for dissecting cellular energy metabolism and lipid biosynthesis. Explore how evidence-backed protocols and troubleshooting strategies make this APExBIO compound a gold standard for metabolic, antimicrobial, and disease modeling studies.

• Amikacin (BAY416651): Molecular Insights and Resistance Dyna

  2026-04-22

  Explore how Amikacin (BAY416651), a robust aminoglycoside antibiotic, enables advanced research on bacterial protein synthesis inhibition and resistance gene dynamics. This article uniquely connects molecular mechanisms with practical assay choices, referencing the latest findings on carbapenem-resistant Enterobacter cloacae.

• Mechanisms of Diuron-Induced Acute Kidney Injury: JAK2/STAT1

  2026-04-21

  This study integrates network toxicology and experimental validation to elucidate how Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) induces acute kidney injury (AKI) via JAK2/STAT1 pathway activation. The findings provide a mechanistic foundation for risk assessment and future research on environmental nephrotoxicity.

• Distinct Roles of PSS2 in SREBP Pathway Regulation Revealed

  2026-04-21

  This study delineates the unique regulatory function of human phosphatidylserine synthase 2 (PSS2) in SREBP pathway modulation, contrasting it with its homolog PSS1. High-resolution cryo-EM and lipidomic analyses uncover the substrate specificity and physiological consequences of PSS2 deficiency, advancing our understanding of phospholipid metabolism and its impact on cellular lipid regulation.

421 records 18/29 page Previous Next First page 上5页 1617181920 下5页 Last page